Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center

Journal of Clinical Oncology

Volumn 13, Issue 4, 1995, Pages 961-968

  Leblond, Véronique ^a   Sutton, Laurent ^b   Dorent, Richard ^b   Davi, Frédéric ^b   Bitker, Marc Olivier ^b   Gabarre, Jean ^b   Charlotte, Frédéric ^b   Ghoussoub, Jean Jacques ^b   Fourcade, Christine ^b   Fischer, Alain ^b   Gandjbakhch, Iradj ^b   Binet, Jacques Louis ^b   Raphael, Martine ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LOMUSTINE; METHOTREXATE; MONOCLONAL ANTIBODY; OKT 3; PREDNISOLONE; PREDNISONE; THYMOCYTE ANTIBODY; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; FEMALE; GENE REARRANGEMENT; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOSUPPRESSIVE TREATMENT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; ORAL DRUG ADMINISTRATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE; TREATMENT OUTCOME;

EID: 0028907566     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.4.961     Document Type: Article

References (45)

1. Penn I: Cancers after cyclosporine therapy. Transplant Proc 20:276-279, 1988 (suppl 1)
2. Penn I: Cancers complicating organ transplantation. N Engl J Med 323:1767-1769, 1990
3. Opelz G, Henderson R, for the Collaborative Transplant Study: Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342:1514-1516, 1993
4. Touraine JL, Bosi E, El Yafo MS, et al: The infectious lymphoproliferative syndrome in transplant patients under immunosuppressive treatment. Transplant Proc 17:96-98, 1985
5. Zutter MM, Martin JP, Sale GE, et al: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520-529, 1988
6. Cleary ML, Sklar J: Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 2:489-493, 1984
7. Leblond V, Raphael M, Sutton L, et al: B-cell lymphoproliferative disorders (BCLD) after cardiac and lung transplantation experience from a single institution and successful therapy. Blood 78:113A, 1991 (suppl 1, abstr)
8. Randhawa PS, Yousem SA, Paradis IL, et al: The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients. Am J Clin Pathol 92:177-185, 1989
9. Polson RJ, Neuberger J, Forman D, et al: De novo malignancies after liver transplantation. Transplant Proc 20:94-97, 1988
10. Hanto DW, Galj-Peczalska KJ, Frizzera G, et al: Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg 198:356-369, 1983
11. Waller EK, Ziemianska M, Bangs CD, et al: Characterization of posttransplant lymphomas that express T-cell-associated markers: Immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice. Blood 82:247-261, 1993
12. Kemnitz J, Cremer J, Gebel M, et al: T-cell lymphoma after heart transplantation. Am J Clin Pathol 94:95-101, 1990
13. Urlich W, Chott A, Watschinger B, et al: Primary peripheral T-cell lymphoma in a kidney transplant under immunosuppression. Hum Pathol 20:1027-1030, 1989
14. Hanto DW, Frizzera G, Galj-Peczalska, et al: Epstein-Barr virus, immunodeficiency, and B-cell lymphoproliferation. Transplantation 39:461-472, 1985
15. Stephan JL, Le Deist F, Blanche S, et al: Treatment of central nervous system B lymphoproliferative syndrome by local infusion of a B cell-specific monoclonal antibody. Transplantation 54:246-248, 1992
16. Fischer A, Blanche S, Le Bidois J, et al: Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324:1451-1456, 1991
17. Elias L, Portlock CS, Rosenberg SA: Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, Adriamycin, vincristine and prednisone (CHOP). Cancer 42:1705-1710, 1978
18. Velasquez WS, Swan F, Redman JR, et al: Combination of etoposide, high-dose Ara-C and solumedrol with or without platinol in relapsing or resistant lymphoma. Proc Am Soc Clin Oncol 8:256A, 1989 (abstr)
19. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al: Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262-4271, 1981
20. Locker J, Nalesnik M: Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135:977-987, 1989
21. Hsu SM, Raine L, Fanger H: Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabelled (PAP) procedures. J Histochem Cytochem 29:577, 1980
22. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphate anti alkaline phosphatase (APAAP complex). J Histochem Cytochem 32:219, 1984
23. Brousset P, Chittal S, Schlaifer, and al: Detection of Epstein-Barr virus mesenger RNA in Reed-Steinberg cells of Hodgkin's disease by in situ hybridization with biotynylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections. Blood 77:1781-1786, 1991
24. Nalesnik MA, Jaffe R, Starzl TE, et al: The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173-192, 1988
25. Smith JL, Wilkinson AH, Hunsicker LG, et al: Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone. Transplant Proc 21:3199-3200, 1989
26. Penn I: The changing pattern of posttransplant malignancies. Transplant Proc 23:1101-1103, 1991
27. Hjelle B, Evans-Holm M, Yen TSB, et al: A poorly differentiated lymphoma of donor origin in a renal allograft recipient. Transplantation 47:945-948, 1989
28. Spiro IA, Yandell DW, Chuan L, et al: Brief report: Lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med 329:27-29, 1993
29. Cleary ML, Warnke F, Sklar J: Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. N Engl J Med 310:477-482, 1984
30. Cleary ML, Nalesnik MA, Shearer WT, et al: Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349-352, 1988
31. Young L, Alfieri C, Henessy K, et al: Expression of Epstein-Barr virus transformation associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080-1085, 1989
32. List AF, Greco A, Vogler LB: Lymphoproliferative diseases in immunocompromised hosts: The role of Epstein-Barr virus. J Clin Oncol 5:1673-1689, 1987
33. Cohen JI: Molecular biology of Epstein-Barr virus and its mechanism of B-cell transformation, pp 48-50, in Straus SE (moderator): Epstein-Barr virus infections: Biology, pathogenesis and management. Ann Intern Med 118:45-58, 1993
34. Rea D, Fourcade C, Leblond V, et al: Patterns of EBV latent and replicative gene expression in EBV B-cell lymphoproliferative disorders after organ transplantation. Transplantation 58:317-324, 1994
35. Pisa P, Cannon MJ, Pisa EK, et al: Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodencient mice are oligoclonal. Blood 79:173-179, 1992
36. Rowe M, Young LS, Crocker J, et al: Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147-158, 1991
37. Garcia RC, Brown NA, Schreck R, et al: B-cell lymphoma in severe combined immunodeficiency not associated with Epstein-Barr virus. Cancer 60:2941-2947, 1987
38. Ho M, Jaffe R, Miller G, et al: The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719-727, 1988
39. Case Records of the Massachusetts General Hospital (Case 4-1985). N Engl J Med 312:226-237, 1985
40. Armitage JM, Kormos RL, Stuart RS, et al: Postransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877-887, 1991
41. Starzl TE, Nalesnik MA, Porter KA, et al: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1:583-588, 1984
42. Murray RJ, Kurilla MG, Griffin HM, et al: Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci USA 87:2906-2910, 1990
43. Pirsch JD, Stratta RJ, Sollinger HW, et al: Treatment of severe Epstein-Barr virus induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation. Am J Med 86:241-244, 1989
44. Shapiro RS, Chauvenet A, McGuire W, et al: Treatment of B-cell lymphoproliferative disorders with interferon a and intravenous gammaglobulin. N Engl J Med 318:1334, 1988 (letter)
45. Baiocchi RA, Caligiuri A: Low dose IL2 prevents the development of Epstein-Barr virus-associated lymphoproliferative disorder in the SCID-human mouse. Blood 82:385A, 1993 (suppl 1, abstr)